SCHEMBL30846415

SCHEMBL30846415

Cc1cncc(-c2ccc(S(=O)(=O)Nc3cccc4cnn(C)c34)cn2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 14/20 0.46
▸ KMT2A Q03164 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ MITF O75030 1/20 0.39
▸ S1PR4 O95977 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ AGTR1 P30556 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CKS1B P61024 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ GLO1 Q04760 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30846413 1.00 SLC40A1 (0.46) SLC40A1KMT2ATDP1MAPTMITF
SCHEMBL27118191 1.00 SLC40A1 (0.46) SLC40A1KMT2ATDP1MAPTMITF
SCHEMBL27118194 0.89 PIK3CA (0.40) SLC40A1GLO1PIK3CA
SCHEMBL30846391 0.89 PTGES2 (0.43) SLC40A1GLO1PIK3CAGAA
SCHEMBL27118083 0.89 PTGES2 (0.43) SLC40A1GLO1PIK3CAGAA
SCHEMBL30846237 0.89 SLC40A1 (0.41) SLC40A1KMT2ATDP1MAPTMITF
SCHEMBL30846482 0.89 PIK3CA (0.40) SLC40A1GLO1PIK3CA
SCHEMBL27118278 0.89 SLC40A1 (0.41) SLC40A1KMT2ATDP1MAPTMITF
SCHEMBL30846465 0.88 SLC40A1 (0.40) SLC40A1KMT2ATDP1MAPTMITF
SCHEMBL27118193 0.88 SLC40A1 (0.40) SLC40A1KMT2ATDP1MAPTMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback